Heart Test Laboratories' Q1 Earnings Miss Expectations
Heart Test Laboratories Q1 Earnings Report
Heart Test Laboratories, a key player in the health sector, recently announced its first-quarter earnings, revealing a GAAP EPS of -$2.64. This result fell short of analysts’ expectations, missing by $0.18. Despite the disappointing earnings, the company holds a cash reserve of $4.3 million, which is crucial for ongoing operations and innovation in health technologies.
Financial Overview
- Q1 GAAP EPS: -$2.64
- Expected EPS: -$2.46
- Cash and Cash Equivalents: $4.3 million
- Shareholder’s Equity: $5.9 million
The company continues its focus on developing significant health solutions, aiming to enhance overall wellness.
Disclaimer: The information provided on this site is for informational purposes only and is not intended as medical advice. We are not responsible for any actions taken based on the content of this site. Always consult a qualified healthcare provider for medical advice, diagnosis, and treatment. We source our news from reputable sources and provide links to the original articles. We do not endorse or assume responsibility for the accuracy of the information contained in external sources.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.